Search clinical trials for: goserelin with dutasteride

Total 17528 results

University of Washington
GlaxoSmithKline; AstraZeneca

Completed

Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer (TAPS)

Cancer | Prostate Neoplasms

United States
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Phase II Dutasteride in Combination With CAB vs CAB in SDC (DUCT)

Salivary Duct Carcinoma

Netherlands
NCIC Clinical Trials Group
National Cancer Institute (NCI); Medical Research Council; Eastern Cooperative... and other collaborators

Completed

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

Canada
GlaxoSmithKline

Completed

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

Androgenetic Alopecia

Japan, Argentina, Peru, Philippines, Taiwan, Mexico, Chile, Russian Federation, Thailand
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
CMX Research
Peptigroupe Inc.

Completed

Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer

Prostate Cancer

Canada, Georgia
Xiangyun Zong
Zhejiang Cancer Hospital

Completed

Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity

Breast Cancer

China
Proton Collaborative Group

Recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Tampere University
Finnish Prostate Cancer Group

Unknown

FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

Patients With T1-4 Advanced Prostate Cancer

Finland
Peking University People's Hospital

Unknown

Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy

Infertility Associated With Endometriosis
Eurofarma Laboratorios S.A.

Recruiting

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Breast Cancer

Breast Cancer

India
AstraZeneca

Completed

Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women

Advanced Breast Cancer

Russian Federation, Ukraine, Czech Republic
Toni Choueiri, MD

Withdrawn

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling

Adenocarcinoma of the Prostate

United States
NCIC Clinical Trials Group
National Cancer Institute (NCI); Southwest Oncology Group

Completed

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

Prostate Cancer

Canada
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
NCIC Clinical Trials Group

Terminated

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer (DART)

Prostate Cancer

Canada
Seattle Institute for Biomedical and Clinical Research
United States Department of Defense; University of Washington

Active, not recruiting

Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia

Metastatic Prostate Cancer | Androgen Deprivation Therapy

United States
Bio-innova Co., Ltd

Not yet recruiting

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Healthy Subjects
GlaxoSmithKline

Completed

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

China
AstraZeneca

Completed

Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

Breast Cancer

Japan
AstraZeneca

Withdrawn

To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. (LARES)

Breast Cancer

China
Ferring Pharmaceuticals

Completed

A Trial of Degarelix in Patients With Prostate Cancer

Prostate Cancer

United States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
Luye Pharma Group Ltd.

Completed

Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Prostate Cancer

China
Peking University People's Hospital

Recruiting

Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients

Breast Cancer

China
424 General Military Hospital
Aristotle University Of Thessaloniki; 251 Hellenic Air Force & VA General Hospital

Completed

BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH

Endometriosis | Bone Density | Muscle | Bone Metabolism

Greece
Ontario Clinical Oncology Group (OCOG)
AstraZeneca

Completed

Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy (ELAAT)

Prostate Cancer

Canada
AstraZeneca

Withdrawn

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy (PROOF)

Breast Cancer | Ovarian Function

Turkey
Luye Pharma Group Ltd.

Completed

Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Prostate Cancer

China
Fudan University

Completed

Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer

Breast Cancer

China
Luye Pharma Group Ltd.

Completed

Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®

Breast Cancer

China
Ferring Pharmaceuticals

Terminated

A Degarelix Trial in Patients With Prostate Cancer

Prostate Cancer

United States, Netherlands, United Kingdom, Hungary, Belgium, Czech Republic, Finland, Germany, Mexico, Poland, Romania, Ukraine, Canada
Gitte Moos Knudsen
Center for Integrated Molecular Brain Imaging, Copenhagen, Denmak; Fertility... and other collaborators

Completed

Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression (GnRHa)

Schizophrenia | Postpartum Depression | Menopause | Major Depressive Disorder | Neurodegeneration | Postpartum Psychosis

Denmark
Mt. Hope Maternity Hospital

Completed

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

Fibroids

Trinidad and Tobago
Eurofarma Laboratorios S.A.

Recruiting

Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

Advanced Prostate Cancer

India
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States, Canada
UNICANCER
AstraZeneca

Completed

Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer

Prostate Cancer

France
National Taiwan University Hospital

Recruiting

Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer

Prostate Cancer

Taiwan
Merckle GmbH

Completed

Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women

Bioequivalence
GlaxoSmithKline

Completed

Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects (ARI115148)

Prostatic Hyperplasia

United States
Seoul National University Hospital
GlaxoSmithKline; The Korean Urological Association

Completed

Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate

Benign Prostatic Hyperplasia
GlaxoSmithKline

Completed

Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects

Prostatic Hyperplasia

Japan
Jinling Hospital, China

Unknown

GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia

Azoospermia

China
Ruijin Hospital

Terminated

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients (COMPETE)

Breast Cancer

China
Northwestern University
GlaxoSmithKline

Terminated

A Clinical Trial Comparing Laser TURP With and Without Dutasteride.

Benign Prostatic Hyperplasia
Endo Pharmaceuticals

Completed

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Prostate Cancer | Adenocarcinoma of the Prostate
Ahon Pharmaceutical Co., Ltd.

Recruiting

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Advanced Breast Cancer | Female Breast Cancer

China
University of British Columbia
British Columbia Cancer Agency

Active, not recruiting

Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT) (ASSERT)

Prostate Cancer

Canada
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group B

Active, not recruiting

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Prostate Cancer

United States, Canada, China, Israel
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Prostate Cancer

United States, Canada
GlaxoSmithKline

Completed

ARI103094-Follow-Up Study for REDUCE Study Subjects

Neoplasms, Prostate

France, Germany, Spain, United States, Netherlands, Canada, United Kingdom, Finland, Chile, Sweden, Argentina, Greece

3

Subscribe